无码欧美成人av天堂456软件,大胆日本熟妇XXXX,9277在线观看免费播放,4p三个男人让我爽了一夜

抗體的生物素化標記實驗要點：

1. 磷酸化血小板源性生長因子受體α/β抗體說明書 如在反應混合液中有疊氮鈉或游離氨基存在,會抑制標記反應。因此,蛋白質在反應前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質之間的分子比按蛋白質表面的ε-氨基的密度會有所不同,選擇不當則影響標記的效率,應先用幾個不同的分子比來篩選最適條件；

3.用NHSB量過量也是不利的,抗原的結合位點可能因此被封閉,導致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等；

5.當游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結合位點時,或位于酶的催化位點時,生物素化會降低或損傷抗體蛋白的結合力或活性；

6.生物素還可能與不同的功能基團,如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價結合；

7.交聯(lián)反應后,應充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結合產生競爭作用；

8.在細胞的熒光標記實驗中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細胞可導致高本底。

產品訂購信息：
英文名稱  Anti-Phospho-PDGFRA(Tyr849)/PDGFRB(Tyr857) 

中文名稱   磷酸化血小板源性生長因子受體α/β抗體說明書 

別    名  PDGF Receptor alpha(Tyr849)/PDGF Receptor beta (Tyr857); Platelet–dirived growth factor receptor-alpha; Alpha platelet derived growth factor receptor; CD 140a; CD140a; CD140a antigen; MGC74795; PDGF alpha chain; PDGF R alpha; PDGFR 2; PDGFR A; PDGFR alpha; PDGFR2; PDGFRA; Platelet derived growth factor receptor 2; Platelet derived growth factor receptor alpha; Platelet derived growth factor receptor alpha polypeptide; PGFRA_HUMAN.

濃    度   1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源   Rabbit

克隆類型   polyclonal

交叉反應   Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Sheep 

產品類型   一抗 磷酸化抗體  

研究領域     免疫學 信號轉導 細胞凋亡 轉錄調節(jié)因子 激酶和磷酸酶 細胞膜受體

蛋白分子量  predicted molecular weight: 117kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PDGF Receptor alpha around the phosphorylation site of Tyr849 [SN(p-Y)VS] 

亞    型   IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化血小板源性生長因子受體α/β抗體說明書 產品應用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產品介紹 The PDGF Receptor Type A (Alpha platelet-derived growth factor receptor precursor, CD140a antigen), a 170kD protein, binds all three isoforms of PDGF with high affinity whereas the PDGF Receptor Type B, a 190kD protein, appears to bind only the PDGF BB homodimer with high affinity. Both receptors are transmembranous, ligand activated protein tyrosine kinases, which phosphorylate a number of important signal transduction proteins, which are bound with differential affinities via SH2 domains. The response of any given cell to PDGF will depend on the types of receptors displayed on the surface and isoforms of PDGF present in the extracellular environment.

Function : Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor.

Subunit : Interacts with homodimeric PDGFA, PDGFB and PDGFC, and with heterodimers formed by PDGFA and PDGFB. Monomer in the absence of bound ligand. Interaction with dimeric PDGFA, PDGFB and/or PDGFC leads to receptor dimerization, where both PDGFRA homodimers and heterodimers with PDGFRB are observed. Interacts (tyrosine phosphorylated) with SHB (via SH2 domain). Interacts (tyrosine phosphorylated) with SHF (via SH2 domain). Interacts (tyrosine phosphorylated) with SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1. Interacts (tyrosine phosphorylated) with PLCG1 (via SH2 domain). Interacts (tyrosine phosphorylated) with CRK, GRB2 and GRB7. Interacts with human cytomegalovirus/HHV-5 envelop glycoprotein B/gB.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Note=The activated receptor is rapidly internalized and degraded.

Post-translational modifications : N-glycosylated.

Ubiquitinated, leading to its degradation (Probable).

Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-731 and Tyr-742 is important for interaction with PIK3R1. Phosphorylation at Tyr-720 and Tyr-754 is important for interaction with PTPN11. Phosphorylation at Tyr-762 is important for interaction with CRK. Phosphorylation at Tyr-572 and Tyr-574 is important for interaction with SRC and SRC family members. Phosphorylation at Tyr-988 and Tyr-1018 is important for interaction with PLCG1.

DISEASE : Note=A chromosomal aberration involving PDGFRA is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). Mutations that cause overexpression and/or constitutive activation of PDGFRA may be a cause of hypereosinophilic syndrome.

Defects in PDGFRA are a cause of gastrointestinal stromal tumor (GIST) [MIM:606764]. Note=Mutations that cause constitutive activation of PDGFRA may be a cause of gastrointestinal stromal tumor (GIST).

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.

Contains 5 Ig-like C2-type (immunoglobulin-like) domains.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P16234.1

細胞膜受體（Membrane Receptors)

PDGFR-α是膜受體，具有酪氨酸酶的活性，與其配體PDGF結合后激活與細胞增殖有關的酶及基因。 PDGFR亦表達于上皮、內皮細胞，、皮膚、腎小球等上皮細胞均有PDGFR表達. 亦有學者報道血小板源性生長因子受體α抗體在細胞胞漿胞膜、胞核都有不同的表達還有人認為：PDGF及其受體一般表達于浸潤組織的細胞附近，組織缺血損傷、腎小球高壓、免疫因素作用、細胞浸潤、實質細胞活化等導致PDGFR表達增強。

抗體的鑒定：

1）磷酸化血小板源性生長因子受體α/β抗體說明書 抗體的效價鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應,瓊脂擴散試驗,酶聯(lián)免疫吸附試驗等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴散試驗來鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應抗原或近似抗原物質的識別能力?？贵w的特異性高,它的識別能力就強。衡量特異性通常以交叉反應率來表示。交叉反應率可用競爭抑制試驗測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計算各自的結合率,求出各自在IC50時的濃度,并按公式計算交叉反應率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質的交叉反應率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結合位點與抗原決定簇之間立體構型的合適度決定的。有助于維持抗原抗體復合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測定對抗體的篩選,確定抗體的用途,驗證抗體的均一性等均有重要意義。

Anti-AT1/FITC 熒光素標記緊張素I抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-Gab2/FITC 熒光素標記接頭蛋白Gab 2抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh CNKSR1 Ras激酶抑制因子連接增強蛋白1抗體 規(guī)格 0.2ml

NSBP1(Nucleosome-binding protein 1) 核小體結合蛋白1(抗原) 0.5mg

IDUA 英文名稱： α-L-艾杜糖苷酶抗體 0.2ml

Rhesus antibody Rh TSARG7 形成相關凋亡蛋白7抗體 規(guī)格 0.2ml

Anti-Gab2/FITC 熒光素標記接頭蛋白Gab 2抗體IgGMulti-class antibodies規(guī)格： 0.2ml

human dopamine,DA ELISA KIT 人多巴胺Multi-class antibodies規(guī)格： 48T

Anti-phospho-SHC (Tyr349) 磷酸化SH2結構域轉化蛋白1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh GPD1 甘油三磷酸脫氫酶1抗體 規(guī)格 0.2ml

Human Cyclin-D2 ELISA Kit 人細胞周期素D2 96T

ORC1L 英文名稱： 起始識別復合蛋白亞基1抗體 0.2ml

BAI2 英文名稱： 腦特異性生成抑制蛋白2抗體 0.2ml

Anti-phospho-SHC (Tyr349) 磷酸化SH2結構域轉化蛋白1抗體Multi-class antibodies規(guī)格： 0.1ml

F XII ELISA Kit 大鼠凝血因子ⅫMulti-class antibodies規(guī)格： 48T

Anti-ERdj5 ERdj5蛋白抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh GMRP1/BTBD10 糖代謝相關蛋白1抗體 規(guī)格 0.2ml

sIgA(Mouse secretory immunoglobulin A) ELISA Kit 小鼠分泌型免疫球蛋白A 96T

Phospho-Nur77(Ser351) 英文名稱： 磷酸化孤兒核受體蛋白Nur77抗體 0.1ml

phospho-Afadin (Ser1721) 英文名稱： 磷酸化絲狀肌動蛋白結合蛋白抗體 0.1ml

Anti-ERdj5 ERdj5蛋白抗體Multi-class antibodies規(guī)格： 0.2ml

CL-0140LLC(小鼠細胞)5×106cells/瓶×2

IFNAR1 Others Cynomolgus 食蟹猴 IFNAR1 / IFNAR 人細胞裂解液 (陽性對照)

人腎小球內皮細胞裂解物HRGECL

A2780細胞，人細胞 鮭魚胚胎細胞,CHSE細胞 腦微內皮細胞Many types of cells包裝：5 × 105次方(1ml)

BNL 1ME A.7R.1(小鼠肝上皮細胞) 5×106cells/瓶×2

HAoSMC Pellet 人主動脈平滑肌細胞團塊 > 1 mio.cells 人無色素睫狀上皮細胞裂解物HNPCEpiCL

CL-0138Lec1(倉鼠卵巢細胞)5×106cells/瓶×2

BDNF Others Mouse 小鼠 / 人 BDNF CHO細胞裂解液 (陽性對照)

人骨骼肌衛(wèi)生細胞裂解物HSkMSCL

貂源細胞 淋巴細胞細胞，A3細胞 3T3-swiss albino細胞，小鼠胚胎成纖維細胞

人胚腎細胞;293 Cells, low passage

HA Others H1N1 甲型 H1N1 (A/New Caledonia/20/1999) 血凝素HA1 (Hemagglutinin) 人細胞裂解液 (陽性對照)

磷酸化血小板源性生長因子受體α/β抗體說明書 IL12B Others Mouse 小鼠 IL12B / IL-12B 人細胞裂解液 (陽性對照)

人細胞;SF126

SD大鼠脂肪間質干細胞 SD rat adipose mesenchymal stem cells

BT-325細胞，人神經細胞 空腸彎曲菌 人胚皮膚成纖維細胞;CCC-ESF-1

SNU-5(人細胞) 5×106cells/瓶×2

Hep G2(人細胞) 5×106cells/瓶×2 CL-0442SK-NEP-1(人腎母細胞瘤細胞)5×106cells/瓶×2 人胚胎肌肉組織來源細胞;CCC-HSM-2